Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.38B
Enterprise Value2.06B
P/E Ratio32.22
PEG Ratio1.13
Price/Sales Ratio8.53
Price/Book Ratio2.71
Enterprise/Revenue7.13
Enterprise/EBITDA26.33

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.27
Operating Margin0.31
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.09

Income Statement

Revenue265.36M
Revenue/Share1.69
Gross Profit102.86M
EBITDA63.09M
Net Income54.21M
Diluted EPS0.34

Balance Sheet

Total Cash749.07M
Total Cash/Share4.68
Total Debt0
Total Debt/Equity0
Current Ratio16.45
Book Value Per Share5.34

Price History

52-Week Change-11.57
52-Week High18.25
52-Week Low11.53
Moving Average 50 Days14.49
Moving Average 200 Days14.72

Statistics

Average Volume4.56M
Shares Outstanding160M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield2.08
Payout Ratio0.66
Last Split Factor2:1
Last Split DateJuly 04, 2017
AD